Christoph Bausch

Christoph Bausch

Geschäftsführer bei SAB BIOTHERAPEUTICS, INC.

Vermögen: - $ am 31.05.2024

53 Jahre
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Christoph Bausch

EinheitArt der EinheitIndustrie
Public Company Biotechnology 21

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Christoph Bausch

UnternehmenSektorVerknüpfte PersonenHauptposition
MERCK & CO., INC. Pharmaceuticals: Major

Frederick Finnegan

Mervyn Turner

William Polvino

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

HAEMONETICS CORPORATION Medical Specialties

Mark Conley

Corporate Officer/Principal

Investment Banks/Brokers

Michael King

Analyst-Equity

Investment Banks/Brokers

Michael King

Analyst-Equity

RADIUS HEALTH, INC. Biotechnology

Mark Conley

Director of Finance/CFO

Investment Banks/Brokers

Michael King

Director of Research - Equity

Miscellaneous Commercial Services

Eddie Sullivan

Director/Board Member

IRON MOUNTAIN INCORPORATED Real Estate Investment Trusts

Mark Conley

Comptroller/Controller/Auditor

VALERITAS HOLDINGS, INC. Medical Specialties

Erick Lucera

Mark Conley

Director of Finance/CFO

Comptroller/Controller/Auditor

Investment Banks/Brokers

Michael King

Analyst-Equity

Investment Banks/Brokers

Michael King

Analyst-Equity

Wholesale Distributors

Mark Conley

Director of Finance/CFO

College/University

Eddie Sullivan

Graduate Degree

Investment Banks/Brokers

Michael King

Analyst-Equity

Amherst College College/University

Andrew Moin

Undergraduate Degree

Boston College College/University

Erick Lucera

William Polvino

Graduate Degree

Undergraduate Degree

Brigham Young University College/University

Eddie Sullivan

Graduate Degree

Oklahoma State University College/University

Mark Conley

Undergraduate Degree

University of Arizona College/University

Christine Hamilton

Eddie Sullivan

Masters Business Admin

Undergraduate Degree

Utah State University College/University

Eddie Sullivan

Graduate Degree

Baruch College College/University

Michael King

Undergraduate Degree

Miscellaneous Commercial Services

Melissa Ullerich

Corporate Officer/Principal

Pharmaceuticals: Major

Eddie Sullivan

Chief Executive Officer

ALAUNOS THERAPEUTICS, INC. Biotechnology

Michael King

Corporate Officer/Principal

THERMO FISHER SCIENTIFIC Medical Specialties

Mark Conley

Director of Finance/CFO

Internet Software/Services

Melissa Ullerich

Corporate Officer/Principal

Public Relations Society of America Foundation, Inc.

Melissa Ullerich

Corporate Officer/Principal

Communication Design Marketing Consultants

Melissa Ullerich

Corporate Officer/Principal

Investment Banks/Brokers

Michael King

Corporate Officer/Principal

Bryant University College/University

Mark Conley

Masters Business Admin

The New York Bar Foundation

Andrew Moin

Corporate Officer/Principal

South Dakota Biotech Association

Christine Hamilton

Eddie Sullivan

Director/Board Member

Founder

The Wharton School of the University of Pennsylvania College/University

Katie Ellias

Masters Business Admin

Harvard Law School College/University

Andrew Moin

Graduate Degree

Investment Managers

Andrew Moin

Analyst-Equity

KALEIDO BIOSCIENCES, INC. Pharmaceuticals: Major

Mark Conley

Corporate Officer/Principal

Investment Managers

Katie Ellias

Private Equity Investor

Pharmaceuticals: Major

Katie Ellias

Director/Board Member

Investment Banks/Brokers

Michael King

Analyst-Equity

Pharmaceuticals: Major

Katie Ellias

Director/Board Member

Statistik

International

Vereinigte Staaten 48

Sektoral

Finance 19
Consumer Services 12
Health Technology 11
Commercial Services 3
Distribution Services 2

Operativ

Director/Board Member 60
Corporate Officer/Principal 52
Undergraduate Degree 19
Founder 16
Independent Dir/Board Member 16
  1. Börse
  2. Insiders
  3. Christoph Bausch
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT